Correlation Between BrainsWay and SurModics
Can any of the company-specific risk be diversified away by investing in both BrainsWay and SurModics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BrainsWay and SurModics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BrainsWay and SurModics, you can compare the effects of market volatilities on BrainsWay and SurModics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BrainsWay with a short position of SurModics. Check out your portfolio center. Please also check ongoing floating volatility patterns of BrainsWay and SurModics.
Diversification Opportunities for BrainsWay and SurModics
Very weak diversification
The 3 months correlation between BrainsWay and SurModics is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding BrainsWay and SurModics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SurModics and BrainsWay is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BrainsWay are associated (or correlated) with SurModics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SurModics has no effect on the direction of BrainsWay i.e., BrainsWay and SurModics go up and down completely randomly.
Pair Corralation between BrainsWay and SurModics
Assuming the 90 days horizon BrainsWay is expected to generate 35.22 times more return on investment than SurModics. However, BrainsWay is 35.22 times more volatile than SurModics. It trades about 0.13 of its potential returns per unit of risk. SurModics is currently generating about 0.04 per unit of risk. If you would invest 315.00 in BrainsWay on September 21, 2024 and sell it today you would earn a total of 538.00 from holding BrainsWay or generate 170.79% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
BrainsWay vs. SurModics
Performance |
Timeline |
BrainsWay |
SurModics |
BrainsWay and SurModics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with BrainsWay and SurModics
The main advantage of trading using opposite BrainsWay and SurModics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BrainsWay position performs unexpectedly, SurModics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SurModics will offset losses from the drop in SurModics' long position.BrainsWay vs. Abbott Laboratories | BrainsWay vs. Stryker | BrainsWay vs. Boston Scientific Corp | BrainsWay vs. Medtronic PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |